Exact Mass: 592.4280076

Exact Mass Matches: 592.4280076

Found 115 metabolites which its exact mass value is equals to given mass value 592.4280076, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

DG(12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (5R,6Z,8E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C35H60O7 (592.4338809999999)

DG(12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (5S,6Z,8E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C35H60O7 (592.4338809999999)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5S,6Z,8E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C35H60O7 (592.4338809999999)

DG(12:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (5S,6Z,8E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C35H60O7 (592.4338809999999)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (5S,8Z,11Z,13E,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C35H60O7 (592.4338809999999)

DG(12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C35H60O7 (592.4338809999999)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C35H60O7 (592.4338809999999)

DG(12:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C35H60O7 (592.4338809999999)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C35H60O7 (592.4338809999999)

DG(12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C35H60O7 (592.4338809999999)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C35H60O7 (592.4338809999999)

DG(12:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C35H60O7 (592.4338809999999)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5R,6Z,8E,10E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C35H60O7 (592.4338809999999)

DG(i-12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C35H60O7 (592.4338809999999)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5S,6Z,8E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C35H60O7 (592.4338809999999)

DG(i-12:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-12:0)

(2S)-2-hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate

C35H60O7 (592.4338809999999)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5S,6E,8Z,11Z,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C35H60O7 (592.4338809999999)

DG(i-12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-12:0/0:0)

(2S)-3-hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C35H60O7 (592.4338809999999)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5R,6E,8Z,11Z,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C35H60O7 (592.4338809999999)

DG(i-12:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5R,6E,8Z,11Z,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C35H60O7 (592.4338809999999)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C35H60O7 (592.4338809999999)

DG(i-12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C35H60O7 (592.4338809999999)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C35H60O7 (592.4338809999999)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

Aromin

C35H60O7 (592.4338809999999)

Montanacin E

C35H60O7 (592.4338809999999)

Ikshusterol 3-O-glucoside

(2R,3R,4S,5S,6R)-2-[[(3S,7S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-7-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O7 (592.4338809999999)

(24R)-24-ethyl-6beta-[(beta-D-glucopyranosyl)oxy]-5beta-cholest-9-ene-12alpha-ol|opuntisteroside

C35H60O7 (592.4338809999999)

N-behenoyl-O-phosphocholineserine

N-docosanoyl-O-phosphocholine-L-serine

C30H61N2O7P (592.4216165999999)

DG(12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C35H60O7 (592.4338809999999)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/12:0/0:0)

C35H60O7 (592.4338809999999)

DG(12:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C35H60O7 (592.4338809999999)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/12:0)

C35H60O7 (592.4338809999999)

DG(12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C35H60O7 (592.4338809999999)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/12:0/0:0)

C35H60O7 (592.4338809999999)

DG(12:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C35H60O7 (592.4338809999999)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/12:0)

C35H60O7 (592.4338809999999)

DG(12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C35H60O7 (592.4338809999999)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/12:0/0:0)

C35H60O7 (592.4338809999999)

DG(12:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C35H60O7 (592.4338809999999)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/12:0)

C35H60O7 (592.4338809999999)

DG(i-12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C35H60O7 (592.4338809999999)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-12:0/0:0)

C35H60O7 (592.4338809999999)

DG(i-12:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C35H60O7 (592.4338809999999)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-12:0)

C35H60O7 (592.4338809999999)

DG(i-12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C35H60O7 (592.4338809999999)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-12:0/0:0)

C35H60O7 (592.4338809999999)

DG(i-12:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C35H60O7 (592.4338809999999)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-12:0)

C35H60O7 (592.4338809999999)

DG(i-12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C35H60O7 (592.4338809999999)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-12:0/0:0)

C35H60O7 (592.4338809999999)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-12:0)

C35H60O7 (592.4338809999999)

PE-Cer 16:0;2O/12:1;O

C30H61N2O7P (592.4216165999999)

PE-Cer 12:0;2O/16:1;O

C30H61N2O7P (592.4216165999999)

PE-Cer 16:1;2O/12:0;O

C30H61N2O7P (592.4216165999999)

PE-Cer 14:1;2O/14:0;O

C30H61N2O7P (592.4216165999999)

PE-Cer 13:1;2O/15:0;O

C30H61N2O7P (592.4216165999999)

PE-Cer 14:0;2O/14:1;O

C30H61N2O7P (592.4216165999999)

PE-Cer 15:0;2O/13:1;O

C30H61N2O7P (592.4216165999999)

PE-Cer 13:0;2O/15:1;O

C30H61N2O7P (592.4216165999999)

PE-Cer 12:1;2O/16:0;O

C30H61N2O7P (592.4216165999999)

PE-Cer 15:1;2O/13:0;O

C30H61N2O7P (592.4216165999999)

[1-carboxy-3-[2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-[(E)-dodec-5-enoyl]oxypropoxy]propyl]-trimethylazanium

C34H58NO7+ (592.4213058)

[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropoxy]propyl]-trimethylazanium

C34H58NO7+ (592.4213058)

[3-[2,3-bis[[(6E,9E)-dodeca-6,9-dienoyl]oxy]propoxy]-1-carboxypropyl]-trimethylazanium

C34H58NO7+ (592.4213058)

[1-carboxy-3-[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(E)-dodec-5-enoyl]oxypropoxy]propyl]-trimethylazanium

C34H58NO7+ (592.4213058)

[1-carboxy-3-[2-[(E)-dec-4-enoyl]oxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium

C34H58NO7+ (592.4213058)

[1-carboxy-3-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropoxy]propyl]-trimethylazanium

C34H58NO7+ (592.4213058)

[1-carboxy-3-[3-[(E)-dec-4-enoyl]oxy-2-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium

C34H58NO7+ (592.4213058)

[1-carboxy-3-[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-octanoyloxypropoxy]propyl]-trimethylazanium

C34H58NO7+ (592.4213058)

2-[hydroxy-[2-nonanoyloxy-3-[(Z)-tetradec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4341918)

[3-[3-butanoyloxy-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium

C34H58NO7+ (592.4213058)

2-[hydroxy-[3-[(Z)-octadec-9-enoxy]-2-pentanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4341918)

[1-carboxy-3-[3-hexanoyloxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C34H58NO7+ (592.4213058)

[3-[3-acetyloxy-2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium

C34H58NO7+ (592.4213058)

2-[[2-heptanoyloxy-3-[(Z)-hexadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4341918)

2-[carboxy-[2-hydroxy-3-[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]oxypropoxy]methoxy]ethyl-trimethylazanium

C34H58NO7+ (592.4213058)

2-[hydroxy-[3-octoxy-2-[(Z)-pentadec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4341918)

2-[[2-butanoyloxy-3-[(Z)-nonadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4341918)

2-[hydroxy-[3-nonoxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4341918)

2-[hydroxy-[2-octanoyloxy-3-[(Z)-pentadec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4341918)

2-[hydroxy-[3-[(Z)-icos-11-enoxy]-2-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4341918)

2-[[2-acetyloxy-3-[(Z)-henicos-11-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4341918)

2-[[3-decoxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4341918)

2-[[2-decanoyloxy-3-[(Z)-tridec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4341918)

2-[[3-[(Z)-heptadec-9-enoxy]-2-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H63NO7P+ (592.4341918)

MGDG O-22:0;O

C31H60O10 (592.418626)

CerPE 14:1;O2/14:0;O

C30H61N2O7P (592.4216165999999)

CerPE 15:1;O2/13:0;O

C30H61N2O7P (592.4216165999999)

CerPE 16:1;O2/12:0;O

C30H61N2O7P (592.4216165999999)

CerPE 17:1;O2/11:0;O

C30H61N2O7P (592.4216165999999)

CerPE 18:1;O2/10:0;O

C30H61N2O7P (592.4216165999999)

CerPE 28:1;O2;O

C30H61N2O7P (592.4216165999999)

SM 14:1;O2/11:0;O

C30H61N2O7P (592.4216165999999)

SM 15:1;O2/10:0;O

C30H61N2O7P (592.4216165999999)

SM 25:1;O2;O

C30H61N2O7P (592.4216165999999)

ST 29:0;O;GlcA

C35H60O7 (592.4338809999999)

ST 29:1;O2;Hex

C35H60O7 (592.4338809999999)

(2r,3r,4s,5s,6r)-2-{[(1s,3as,3bs,7s,9ar,9br,11as)-1-[(2r,5s)-7-hydroxy-5-isopropylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1s,3as,3bs,7s,9ar,9br,11as)-1-[(2r,5s)-7-hydroxy-5-isopropylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O7 (592.4338809999999)

(5s)-3-{[(2s,6r)-6-[(7s)-7-hydroxy-7-[(2s,5r)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]-2-oxoheptyl]oxan-2-yl]methyl}-5-methyl-5h-furan-2-one

C35H60O7 (592.4338809999999)

2-{[1-(7-hydroxy-5-isopropylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O7 (592.4338809999999)

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,4r,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-4-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,4r,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-4-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O7 (592.4338809999999)